More News
Want to Read Locked Articles?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Viatris to Acquire Oyster Point and India-Based Famy Life Sciences for $705 Million
Author: Peter Downs and Jennie Crabbe
Viatris put the ophthalmology business world on notice on Nov. 7 with a major step toward its goal of becoming “the next global ophthalmology leader.” The Pittsburgh company announced a $705 million spend to set up a new ophthalmic business unit through the acquisitions of Oyster Point Pharma and Famy Life Sciences. US-based Oyster Point is the maker of Tyrvaya nasal spray for dry eye. India-based Famy has a pipeline of late-stage candidates for dry eye, blepharitis, and presbyopia. The acqui...
